Published in Radiographics on October 01, 2009
Non-invasive quantification of white and brown adipose tissues and liver fat content by computed tomography in mice. PLoS One (2012) 0.97
Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging (2014) 0.94
Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse. Invest Radiol (2012) 0.87
Quantification of liver iron content with CT-added value of dual-energy. Eur Radiol (2011) 0.86
Visualization of acute liver damage induced by cycloheximide in rats using PET with [(18)F]FEDAC, a radiotracer for translocator protein (18 kDa). PLoS One (2014) 0.79
Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine. Hepat Med (2010) 0.75
Separation of hepatic iron and fat by dual-source dual-energy computed tomography based on material decomposition: an animal study. PLoS One (2014) 0.75
Expectations from imaging for pre-transplant evaluation of living donor liver transplantation. World J Radiol (2014) 0.75
Review of internal hernias: radiographic and clinical findings. AJR Am J Roentgenol (2006) 5.32
Phase I trial of pazopanib in patients with advanced cancer. Clin Cancer Res (2009) 2.63
Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions. Radiology (2012) 2.51
Renal stone assessment with dual-energy multidetector CT and advanced postprocessing techniques: improved characterization of renal stone composition--pilot study. Radiology (2009) 1.90
Endovascular treatment of visceral artery aneurysms. J Endovasc Ther (2002) 1.75
Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol (2010) 1.70
Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology (2008) 1.41
Challenges in screening for hepatocellular carcinoma in the glycogen storage disease type 1a population. Intern Med (2012) 1.38
A review of MR physics: 3T versus 1.5T. Magn Reson Imaging Clin N Am (2007) 1.37
Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol (2010) 1.33
Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen. Invest Radiol (2010) 1.17
Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging (2012) 1.08
Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging. Korean J Radiol (2011) 1.04
Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? J Magn Reson Imaging (2012) 1.03
Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome. Radiology (2004) 1.02
Time-resolved MR angiography as a useful sequence for assessment of ovarian vein reflux. AJR Am J Roentgenol (2009) 0.98
Calcified vascular plaque specimens: assessment with cardiac dual-energy multidetector CT in anthropomorphically moving heart phantom. Radiology (2008) 0.97
Multislice helical CT of the pancreas and spleen. Eur J Radiol (2003) 0.95
Focal cystic high-attenuation lesions: characterization in renal phantom by using photon-counting spectral CT--improved differentiation of lesion composition. Radiology (2010) 0.94
MRI of the pelvis in women: 3D versus 2D T2-weighted technique. AJR Am J Roentgenol (2010) 0.94
Central veins of the chest: evaluation with time-resolved MR angiography. Radiology (2008) 0.93
N/2 ghosting artifacts: elimination at 3.0-T MR cholangiography with SPACE pulse sequence. Radiology (2008) 0.93
Coronary stent patency: dual-energy multidetector CT assessment in a pilot study with anthropomorphic phantom. Radiology (2008) 0.93
Differentiating a chronic hyperplastic mass from pancreatic cancer: a challenge remaining in multidetector CT of the pancreas. Eur Radiol (2003) 0.91
Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging. Eur Radiol (2010) 0.91
Improvement in B1-inhomogeneity artifacts in the abdomen at 3T MR imaging using a radiofrequency cushion. J Magn Reson Imaging (2008) 0.90
Multi-detector row CT of the small bowel: peak enhancement temporal window--initial experience. Radiology (2007) 0.89
Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions? J Magn Reson Imaging (2011) 0.89
Abdominal magnetic resonance imaging at 3.0 T what is the ultimate gain in signal-to-noise ratio? Acad Radiol (2006) 0.88
Assessment of automatic vessel tracking techniques in preoperative planning of transluminal aortic stent graft implantation. J Comput Assist Tomogr (2004) 0.87
Do surgical clips interfere with radiofrequency thermal ablation? AJR Am J Roentgenol (2003) 0.87
Comparison of ECG-gated rectilinear vs. real-time radial K-space sampling schemes in cine True-FISP cardiac MRI. J Cardiovasc Magn Reson (2004) 0.87
Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination. Eur J Radiol (2011) 0.86
Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents. AJR Am J Roentgenol (2010) 0.86
Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience. Radiology (2008) 0.86
Practice patterns in imaging of the pregnant patient with abdominal pain: a survey of academic centers. AJR Am J Roentgenol (2007) 0.86
Abdominal pain: coronal reformations from isotropic voxels with 16-section CT--reader lesion detection and interpretation time. Radiology (2007) 0.86
Detection of renal lesion enhancement with dual-energy multidetector CT. Radiology (2011) 0.86
Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium. AJR Am J Roentgenol (2012) 0.85
Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal? Eur J Radiol (2010) 0.85
Functional evaluation of cystic duct patency with Gd-EOB-DTPA MR imaging: an alternative to hepatobiliary scintigraphy for diagnosis of acute cholecystitis? Abdom Imaging (2012) 0.84
Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein. AJR Am J Roentgenol (2011) 0.83
MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography? AJR Am J Roentgenol (2013) 0.83
Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. Eur J Radiol (2011) 0.83
Pilot study assessing differentiation of steatosis hepatis, hepatic iron overload, and combined disease using two-point dixon MRI at 3 T: in vitro and in vivo results of a 2D decomposition technique. AJR Am J Roentgenol (2010) 0.82
Consensus report from the 6th International forum for liver MRI using gadoxetic acid. J Magn Reson Imaging (2013) 0.82
Functional cardiac CT and MR: effects of heart rate and software applications on measurement validity. J Thorac Imaging (2005) 0.82
Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. Eur J Radiol (2010) 0.82
Automated patient-tailored screening of the liver for diffuse steatosis and iron overload using MRI. AJR Am J Roentgenol (2013) 0.80
Effectiveness of a three-dimensional dual gradient echo two-point Dixon technique for the characterization of adrenal lesions at 3 Tesla. Eur Radiol (2011) 0.80
Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model. J Magn Reson Imaging (2012) 0.80
Evaluation of MRI acquisition workflow with lean six sigma method: case study of liver and knee examinations. AJR Am J Roentgenol (2010) 0.80
Gadofosveset-enhanced magnetic resonance angiography of the thoracic vasculature in the equilibrium phase: feasibility and impact of dose. J Comput Assist Tomogr (2013) 0.80
Comparison of MR imaging sequences for liver and head and neck interventions: is there a single optimal sequence for all purposes? Acad Radiol (2004) 0.80
Imaging at higher magnetic fields: 3 T versus 1.5 T. Magn Reson Imaging Clin N Am (2010) 0.80
Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent. AJR Am J Roentgenol (2013) 0.79
Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable? Radiology (2010) 0.79
Magnetic resonance (MR) cholangiography: quantitative and qualitative comparison of 3.0 Tesla with 1.5 Tesla. Invest Radiol (2007) 0.79
Multidetector CT angiography of arterial inflow and runoff in the lower extremities: a challenge in data acquisition and evaluation. J Endovasc Ther (2004) 0.78
Contrast-enhanced magnetic resonance angiography: first-pass arterial enhancement as a function of gadolinium-chelate concentration, and the saline chaser volume and injection rate. Invest Radiol (2012) 0.78
MR cholangiopancreatography: 1.5T versus 3T. Magn Reson Imaging Clin N Am (2007) 0.78
Effect of varying injection rates of a saline chaser on aortic enhancement in CT angiography: phantom study. Eur Radiol (2008) 0.78
Characterization of adrenal lesions: comparison of 2D and 3D dual gradient-echo MR imaging at 3 T--preliminary results. Radiology (2010) 0.78
Quantitative dynamic contrast-enhanced MRI of pelvic and lumbar bone marrow: effect of age and marrow fat content on pharmacokinetic parameter values. AJR Am J Roentgenol (2013) 0.78
Effect of organ enhancement and habitus on estimation of unenhanced attenuation at contrast-enhanced dual-energy MDCT: concepts for individualized and organ-specific spectral iodine subtraction strategies. AJR Am J Roentgenol (2011) 0.78
Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion. J Magn Reson Imaging (2013) 0.77
MR-guided percutaneous sclerotherapy of low-flow vascular malformations in the head and neck. Magn Reson Imaging Clin N Am (2005) 0.77
Assessment of the optimal temporal window for intravenous CT cholangiography. Eur Radiol (2007) 0.77
Impact of precontrast T10 relaxation times on dynamic contrast-enhanced MRI pharmacokinetic parameters: T10 mapping versus a fixed T10 reference value. J Magn Reson Imaging (2014) 0.76
Time-resolved MR angiography of the central veins of the chest. AJR Am J Roentgenol (2008) 0.76
Automated liver sampling using a gradient dual-echo Dixon-based technique. Magn Reson Med (2011) 0.76
Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine. Eur J Radiol (2011) 0.76
Femur: MR imaging-guided radio-frequency ablation in a porcine model-feasibility study. Radiology (2002) 0.76
Assessment of the myocardium on 2-phase cardiac multidetector computed tomography: does cyclic cardiac contraction influence myocardial attenuation? J Comput Assist Tomogr (2008) 0.75
Lesion detection and assessment of extrahepatic findings in abdominal MRI using hepatocyte specific contrast agents--comparison of Gd-EOB-DTPA and Gd-BOPTA. BMC Med Imaging (2013) 0.75
Implementation of graphic user interface screen capture solution for workflow assessment of abdominal MR examinations valuable tool to analyze discrepancies in expected and experienced MR table time. Acad Radiol (2009) 0.75
Abdominal magnetic resonance imaging at 3 T: oncological applications. Top Magn Reson Imaging (2010) 0.75
Bone marrow enhancement during time-resolved magnetic resonance angiography of the pelvis. J Comput Assist Tomogr (2013) 0.75
Gradient shimming during magnetic resonance imaging of the liver: comparison of a standard protocol versus a novel reduced protocol. Invest Radiol (2012) 0.75
Low-dose unenhanced CT for IV contrast bolus timing: is it reliable to assess hepatic steatosis? Acad Radiol (2011) 0.75
Assessment of parallel acquisition techniques in adrenal magnetic resonance imaging: does increased temporal resolution significantly improve visualization of adrenal lesions? Acad Radiol (2004) 0.75
Respiratory-gated noncontrast SPACE MR angiography sequence at 3T for evaluation of the central veins of the chest: a feasibility study. J Magn Reson Imaging (2013) 0.75
Imaging appearance of surgical sponges at 1.5 T MRI: an in vitro study. Eur J Radiol (2010) 0.75
Multislice helical CT of the abdomen. Eur Radiol (2002) 0.75
Diagnosis of a solitary cardiac metastasis from ocular melanoma. J Thorac Cardiovasc Surg (2005) 0.75
Contrast-enhanced 3D MRA of the aortoiliac and infrainguinal arteries when conventional transfemoral arteriography is not feasible. J Endovasc Ther (2002) 0.75
Contrast-enhanced hepatic magnetic resonance angiography at 3 T: does parallel imaging improve image quality? J Comput Assist Tomogr (2007) 0.75